4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001144204-16-137317
Director bought 333,333 shares at $1.49 ($496,666)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NEIS JOHN Director | 2016-11-29 | Purchase | +333,333 | $1.49 | $496,666 | 631,317 | I: show line 1 in the form |
| Open-market purchases · 333,333 sh · avg $1.49 · $496,666 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| NEIS JOHN Director | 2016-11-29 | Purchase · Series C Warrants (right to buy) | +333,333 | $0.01 | $3,333 | 607,946 | I: show line 2 in the form |
Loading xslF345X03/v454220_4.xml…